Table 3 Estimated prevalence of chronic HCV infection and estimated number of affected individuals, 2013–2014, Belgium
From: Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
Demographic characteristic | HCV chronic infection 2013–2014 | |||||
|---|---|---|---|---|---|---|
Number in study sample | Prevalence in Belgium | Individuals in Belgium | ||||
% | 95% CI | n | 95% CI | |||
Sex | Female | 1 | 0.04 | 0.005–0.34 | 2280 | 280–18,950 |
Male | 3 | 0.20 | 0.05–0.85 | 10,770 | 2500–46,130 | |
Region | Brussels-Capital | 0 | 0 | 0–0.99 | 0 | 0–11,430 |
Flanders | 4 | 0.21 | 0.07–0.66 | 13,300 | 4130–42,180 | |
Wallonia | 0 | 0 | 0–0.46 | 0 | 0–16,390 | |
Age group (in years) | < 20 | 1 | 0.08 | 0.01–0.54 | 1990 | 290–13,700 |
≥20 | 3 | 0.13 | 0.04–0.43 | 10,900 | 3220–36,790 | |
20–29 | 0 | 0 | 0–0.98 | 0 | 0–13,670 | |
30–39 | 1 | 0.31 | 0.04–2.27 | 4490 | 600–32,890 | |
40–49 | 1 | 0.13 | 0.02–1.14 | 2150 | 250–18,230 | |
50–59 | 1 | 0.27 | 0.03–2.3 | 4180 | 490–35,130 | |
60–69 | 0 | 0 | 0–2.07 | 0 | 0–24,980 | |
70–79 | 0 | 0 | 0–4.51 | 0 | 0–36,840 | |
≥80 | 0 | 0 | 0–3.66 | 0 | 0–21,480 | |
All | 4 | 0.12 | 0.03–0.41 | 13,320 | 3770–45,510 | |